Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,438−100.0%Sold outHolders
Q1 20262,438$35.3K<0.1%+187+8.3%AddedHolders
Q4 20252,251$32.1K<0.1%00.0%UnchangedHolders
Q3 20252,251$17.7K<0.1%+1,148+104.1%AddedHolders
Q2 20251,103$6.32K<0.1%−249−18.4%ReducedHolders
Q1 20251,352$11.0K<0.1%−3,532−72.3%ReducedHolders
Q4 20244,884$46.0K<0.1%−7,132−59.4%ReducedHolders
Q3 202412,016$128.3K<0.1%−12,846−51.7%ReducedHolders
Q2 202424,862$246.6K<0.1%+984+4.1%AddedHolders
Q1 202423,878$281.3K<0.1%−3,316−12.2%ReducedHolders
Q4 202327,194$385.9K<0.1%+3,591+15.2%AddedHolders
Q3 202323,603$287.0K<0.1%−706−2.9%ReducedHolders
Q2 202324,309$305.3K<0.1%−8,564−26.1%ReducedHolders
Q1 202332,873$364.6K<0.1%+1,812+5.8%AddedHolders
Q4 202231,061$379.3K<0.1%−16,498−34.7%ReducedHolders
Q3 202247,559$498.0K<0.1%−1,733−3.5%ReducedHolders
Q2 202249,292$529.0K<0.1%+34,243+227.5%AddedHolders
Q1 202215,049$143.0K<0.1%+14,960+16,809.0%AddedHolders
Q4 202189$1.00K<0.1%−10,818−99.2%ReducedHolders
Q3 202110,907$104.0K<0.1%−2,275−17.3%ReducedHolders
Q2 202113,182$127.0K<0.1%+1,955+17.4%AddedHolders
Q1 202111,227$111.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.